TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
203,397
|
160,003
|
228,073 |
Financial expenses |
57
|
0
|
40 |
Earnings before taxes |
16,772
|
17,736
|
50,551 |
EBITDA |
17,008
|
17,058
|
50,819 |
Total assets |
46,830
|
35,247
|
64,738 |
Current assets |
43,393
|
32,132
|
62,034 |
Current liabilities |
27,274
|
19,640
|
24,211 |
Equity capital |
17,774
|
14,670
|
40,527 |
- share capital |
101
|
95
|
98 |
Employees (average) |
91
|
65
|
80 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.0%
|
41.6%
|
62.6% |
Turnover per employee |
2,235
|
2,462
|
2,851 |
Profit as a percentage of turnover |
8.2%
|
11.1%
|
22.2% |
Return on assets (ROA) |
35.9%
|
50.3%
|
78.1% |
Current ratio |
159.1%
|
163.6%
|
256.2% |
Return on equity (ROE) |
94.4%
|
120.9%
|
124.7% |
Change turnover |
32,040
|
-61,216
|
121,736 |
Change turnover % |
19%
|
-28%
|
114% |
Chg. No. of employees |
26
|
-15
|
31 |
Chg. No. of employees % |
40%
|
-19%
|
63% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.